Yu, Huixin
Janssen, Julie M.
de Weger, Vincent A.
Nuijen, Bastiaan
Stuurman, Rik E.
Marchetti, Serena
Schellens, Jan H. M.
Beijnen, Jos H.
Dorlo, Thomas P. C.
Huitema, Alwin D. R.
Article History
Received: 22 January 2020
Accepted: 7 April 2020
First Online: 19 April 2020
Compliance with ethical standards
:
: BN, JB and JS are inventors and hold a patent on oral ModraDoc formulations. JB and JS are part-time employees and shareholders in Modra Pharmaceuticals, a spinout company developing oral taxane formulations. HY, JJ, VW, RS, SM, TD and AH declare that they have no conflict of interest.
: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the clinical studies.